# Assessing the Effects of Alfacalcidol Intake on Expression of Involed Gene in Metabolism in Obese Subjects

> **NCT01752244** · NA · UNKNOWN · sponsor: **Tehran University of Medical Sciences** · enrollment: 94 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DIETARY_SUPPLEMENT:** Placebo
- **DIETARY_SUPPLEMENT:** Alfacalcidol

## Key facts

- **NCT ID:** NCT01752244
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2012-12
- **Final completion:** 2013-01
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2012-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01752244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01752244, "Assessing the Effects of Alfacalcidol Intake on Expression of Involed Gene in Metabolism in Obese Subjects". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01752244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*